Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII

75Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The development of inhibitors in hemophiliacs is a severe complication of factor VIII (FVIII) replacement therapy and is a process driven by FVIII specific T helper cells. Objectives: To finely map T cell epitopes within the whole FVIII protein in order to investigate the possibility of engineering FVIII variants with reduced propensity for inhibitor development. Patients and methods: T cell lines were generated from five patients with severe hemophilia who had developed inhibitors, and were screened for T cell proliferation against pools of overlapping peptides spanning the entire B domain deleted (BDD) FVIII sequence. Positive peptide pools were decoded by screening individual peptides against the T cell lines. Positive peptides, and mutants thereof, were tested for their ability to bind major histocompatibility complex (MHC) Class II and stimulate T cell proliferation in a panel of healthy donors. The activities of the corresponding mutant proteins were assessed via chromogenic assay. Results: One peptide, spanning FVIII amino acids 2098-2112, elicited a vigorous response from one hemophiliac donor, induced strong T cell responses in the panel of healthy donors and bound to a number of HLA-DR alleles. Mutations were made in this peptide that removed its ability to stimulate T cells of healthy donors and to bind to MHC Class II while retaining full activity when incorporated into a mutant BDD-FVIII protein. Conclusions: Fine T cell epitope mapping of the entire FVIII protein is feasible, although challenging, and this knowledge may be used to create FVIII variants which potentially have reduced immunogenicity. © 2005 International Society on Thrombosis and Haemostasis.

References Powered by Scopus

Several common HLA-DR types share largely overlapping peptide binding repertoires

568Citations
N/AReaders
Get full text

Promiscuous and allele-specific anchors in HLA-DR-binding peptides

387Citations
N/AReaders
Get full text

The life cycle of coagulation factor VIII in view of its structure and function

376Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis

371Citations
N/AReaders
Get full text

Immunogenicity of protein therapeutics: The key causes, consequences and challenges

308Citations
N/AReaders
Get full text

Aldehyde tag coupled with HIPS chemistry enables the production of ADCs conjugated site-specifically to different antibody regions with distinct in vivo efficacy and PK outcomes

183Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jones, T. D., Phillips, W. J., Smith, B. J., Bamford, C. A., Nayee, P. D., Baglin, T. P., … Bakert, M. P. (2005). Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII. Journal of Thrombosis and Haemostasis, 3(5), 991–1000. https://doi.org/10.1111/j.1538-7836.2005.01309.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

47%

Researcher 16

42%

Professor / Associate Prof. 3

8%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 22

51%

Medicine and Dentistry 11

26%

Biochemistry, Genetics and Molecular Bi... 7

16%

Immunology and Microbiology 3

7%

Save time finding and organizing research with Mendeley

Sign up for free